Light Therapy in End Stage Kidney Disease - Trial NCT06310161
Access comprehensive clinical trial information for NCT06310161 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Pennsylvania and is currently Not yet recruiting. The study focuses on End Stage Renal Disease. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Pennsylvania
Timeline & Enrollment
N/A
Aug 01, 2024
Mar 01, 2025
Primary Outcome
Fatigue Severity Scale
Summary
The goal of this clinical trial is to test light therapy in patients with end stage kidney
 disease who are receiving hemodialysis. The main aim is to determine if light therapy
 decreases fatigue severity. Participants will receive light therapy using special glasses for
 one hour during the dialysis sessions for four weeks of treatment.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06310161
Device Trial